Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
AB Sciex

Industry News

GlaxoSmithKline Boosts Global Cancer Testing With GE Healthcare Deal

The new agreement between GE Healthcare-subsidiary Clarient and GlaxoSmithKline will create a force in cancer testing, according to Kalorama Information.   More...
20 Oct 2014

Emergency Approval of Ebola Test Suggests Opportunity for Test Makers

The emergency approval of a real-time PCR test for Zaire Ebolavirus demonstrates the scope of concern about the recent epidemic and a possible opportunity for test makers.   More...
07 Oct 2014
DRG International
DiagCor Bioscience
77 ELEKTRONIKA
Image: PointMan provides a reliable, efficient, highly sensitive determination of the presence or absence of a mutation in the DNA sequence (Photo courtesy of EKF Diagnostics).

EKF and Mass. General Collaborate to Develop Blood Tests for Cancer Patients

EKF Molecular and Massachusetts General Hospital have entered into a 2-year research collaboration to develop PointMan assays that can effectively detect treatable cancer mutations in blood samples.   More...
06 Oct 2014

Merck KGaA to Buy Sigma-Aldrich for USD 17 Billion

Merck KGaA will acquire Sigma-Aldrich for USD 17 billion, expanding its business in North America and gaining exposure in Asia.  More...
29 Sep 2014

Initiative Launched to Make Genetic Profiles a Routine Part of Clinical Decisions

Laboratory Corporation of America Holdings has launched “Enlighten Health Genomics,” a new business that builds on the diagnostic potential of next-generation sequencing technology.  More...
23 Sep 2014
Life Technologies

Funding Awarded to Develop Diagnostic Point-of-Care Device for Sickle Cell Disease

Rockland Immunochemicals has announced the award of a Small Business Innovation Research grant from the NIH National Heart Lung and Blood Institute to develop an antibody-based point-of-care device for the diagnosis of Sickle Cell Disease.  More...
22 Sep 2014

First European Company Obtains CE-IVD Marking for Next Generation Sequencing in Routine Testing

For the first time, a European company, Sophia Genetics, has obtained the CE-IVD mark for clinical use of Next Generation Sequencing bioinformatics pipeline for routine genetic testing.  More...
16 Sep 2014


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
 
Copyright © 2000-2014 Globetech Media. All rights reserved.